Europe
Sensyne Health plc, the British clinical AI technology company, announces that its Annual Report and Accounts for the year ended 30 April 2019 is now available on the Group’s website at www.sensynehealth.com/investors.
Sensyne Health plc, the British clinical AI technology company, announced it has signed agreements with a Fortune 200 company and a data infrastructure specialist to launch and scale its digital health products under licence in the U.S.
Sensyne Health plc, the British Clinical AI technology company, announces its audited full year results for the 12 months ended 30 April 2019.
Santhera Pharmaceuticals announces presentation of data showing continued improvement of muscle function and improved tolerability compared with corticosteroids of 18-month vamorolone treatment in Duchenne muscular dystrophy.
People with Alzheimer’s disease who used antipsychotic drugs had a higher number of accumulated hospital days than people with Alzheimer’s disease who did not use antipsychotics, according to a new study from the University of Eastern Finland.
The two companies will partner on the process development, analytical development and large-scale manufacturing for late-stage clinical and commercial supply.
Under the terms of the deal, 4D will use its proprietary MicroRx platform with Merck’s expertise in novel vaccine development and commercialization to discover and develop Live Biotherapeutics as vaccines in up to three currently undisclosed indications.
The approval of Beovu was based on findings from the Phase III HAWK and HARRIER clinical trials, in which Novartis’ drug demonstrated non-inferiority versus Eylea in mean change in best-corrected visual acuity at 48 weeks.
Promore Pharma AB published on 4 October 2019 the timetable for the rights issue of shares in a press release, where the record date was incorrectly stated in the text.
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
PRESS RELEASES